Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01860963 · ClinicalTrials.gov registry record · NA
Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 310
- Enrollment target
NCT01860963: Completed NA study, sponsored by Stanford University.
NCT01860963 is a NA study that has completed, run by Stanford University. The registered enrollment target is 310 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01860963, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 310 participants
- Enrollment target
Study Summary
This study is designed to establish the prevalence of anal squamous intraepithelial lesion (ASIL) in patients with inflammatory bowel disease (IBD) and healthy controls.
Interventions
- PROCEDURE Anal Pap smear and HPV DNA testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 310 participants |
| Start Date | 2010-01 |
| Est. Completion | 2013-06 |
| Phase | NA |
What the finished NCT01860963 record still lists
NCT01860963 is an interventional study that assigns participants to a tested intervention. The registered 310 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 1 intervention - of which Anal Pap smear and HPV DNA testing is the first listed.
NCT01860963 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01860963 about?
NCT01860963 is a clinical study titled "Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls". This study is designed to establish the prevalence of anal squamous intraepithelial lesion (ASIL) in patients with inflammatory bowel disease (IBD) and healthy controls.
What is the current status of trial NCT01860963?
This trial is currently completed. It is a NA study. The enrollment target is 310 participants. The study started on 2010-01. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01860963?
The interventions under investigation include: Anal Pap smear and HPV DNA testing (PROCEDURE).
Who is sponsoring clinical trial NCT01860963?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01860963's enrollment target sits among peer trials
310 323rd of 2000 higher than 1,678 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03039439 · 310 participants
Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
- NCT04178018 · 310 participants · NA
Transvaginal Ultrasound and Photoacoustic Imaging of Ovary
- NCT04878094 · 310 participants · Phase 3
A Study of Intra-operative Imaging in Women With Ovarian Cancer
- NCT05459233 · 310 participants · NA
Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia